Moderna, Inc. (MRNA) - Risk-Adjusted Returns & Sharpe Ratio | pfolio
Moderna, Inc. (MRNA): 1Y return 696.6%, Sharpe ratio 1.59, volatility 189.9%, max drawdown -34.2%. A Stock in the Equity asset class. Compare MRNA with other assets and invest through your own broker with pfolio.
Moderna, Inc. (MRNA) Overview
- Type: Stock
- Asset Class: Equity
- Region: Americas
- Country: US (Developed)
- Currency: USD
MRNA Performance
- MTD
- Return: 11.0%, Sharpe: 3.44, Volatility: 111.3%, Max Drawdown: -7.8%
- YTD
- Return: 624.8%, Sharpe: 1.75, Volatility: 212.3%, Max Drawdown: -34.2%
- 1Y
- Return: 696.6%, Sharpe: 1.59, Volatility: 189.9%, Max Drawdown: -34.2%
- 5Y
- Return: -31.3%, Sharpe: 0.29, Volatility: 102.3%, Max Drawdown: -93.9%
Frequently Asked Questions
- What is Moderna, Inc. (MRNA)?
- Moderna, Inc. (MRNA) is a Stock in the Equity asset class. pfolio shows its cumulative return, volatility, Sharpe ratio, and max drawdown across MTD, YTD, 1Y, 5Y, 10Y, 20Y, and all-time periods.
- How does MRNA compare to other assets?
- You can compare MRNA with any other asset using pfolio's comparison tool, which ranks assets side-by-side by risk-adjusted returns.
- Can I invest in MRNA through pfolio?
- pfolio helps you build diversified portfolios that may include MRNA. You invest through your own broker — pfolio provides the analytics.